Report Detail
COVID-19 Impact on Global Biopharmaceutical and Vaccines Market Size, Status and Forecast 2020-2026
- RnM3985262 |
- 03 June, 2020 |
- Global |
- 95 Pages |
- QYResearch |
- Other
Biopharmaceuticals and vaccines are well recognized for their potential in treating incurable diseases for which conventional low-molecular-weight pharmaceuticals produced by chemical synthesis are ineffective and for preventing infectious diseases.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Biopharmaceutical and Vaccines market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Biopharmaceutical and Vaccines industry.
Based on our recent survey, we have several different scenarios about the Biopharmaceutical and Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Biopharmaceutical and Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biopharmaceutical and Vaccines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biopharmaceutical and Vaccines market in terms of revenue.
Players, stakeholders, and other participants in the global Biopharmaceutical and Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Biopharmaceutical and Vaccines market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Biopharmaceutical and Vaccines market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biopharmaceutical and Vaccines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biopharmaceutical and Vaccines market.
The following players are covered in this report:
Novartis
Pfizer
Sanofi
Roche
Abbott
Biogen Idec
Regeneron Pharmaceuticals
Alexion Pharmaceuticals
Johnson and Johnson
GlaxoSmithKline
Merck
Lonza
Boehringer Ingelheim
Rentschler
Biopharmaceutical and Vaccines Breakdown Data by Type
Biopharmaceutical
Vaccine Production
Biopharmaceutical and Vaccines Breakdown Data by Application
Pharmaceuticals Industry
Clinical Diagnosis
Scientific Research
Others
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Biopharmaceutical and Vaccines Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Biopharmaceutical and Vaccines Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Biopharmaceutical
- 1.4.3 Vaccine Production
- 1.5 Market by Application
- 1.5.1 Global Biopharmaceutical and Vaccines Market Share by Application: 2020 VS 2026
- 1.5.2 Pharmaceuticals Industry
- 1.5.3 Clinical Diagnosis
- 1.5.4 Scientific Research
- 1.5.5 Others
- 1.6 Coronavirus Disease 2019 (Covid-19): Biopharmaceutical and Vaccines Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Biopharmaceutical and Vaccines Industry
- 1.6.1.1 Biopharmaceutical and Vaccines Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Biopharmaceutical and Vaccines Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Biopharmaceutical and Vaccines Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Biopharmaceutical and Vaccines Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Biopharmaceutical and Vaccines Market Perspective (2015-2026)
- 2.2 Biopharmaceutical and Vaccines Growth Trends by Regions
- 2.2.1 Biopharmaceutical and Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Biopharmaceutical and Vaccines Historic Market Share by Regions (2015-2020)
- 2.2.3 Biopharmaceutical and Vaccines Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Biopharmaceutical and Vaccines Market Growth Strategy
- 2.3.6 Primary Interviews with Key Biopharmaceutical and Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Biopharmaceutical and Vaccines Players by Market Size
- 3.1.1 Global Top Biopharmaceutical and Vaccines Players by Revenue (2015-2020)
- 3.1.2 Global Biopharmaceutical and Vaccines Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Biopharmaceutical and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Biopharmaceutical and Vaccines Market Concentration Ratio
- 3.2.1 Global Biopharmaceutical and Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical and Vaccines Revenue in 2019
- 3.3 Biopharmaceutical and Vaccines Key Players Head office and Area Served
- 3.4 Key Players Biopharmaceutical and Vaccines Product Solution and Service
- 3.5 Date of Enter into Biopharmaceutical and Vaccines Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Biopharmaceutical and Vaccines Historic Market Size by Type (2015-2020)
- 4.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Type (2021-2026)
5 Biopharmaceutical and Vaccines Breakdown Data by Application (2015-2026)
- 5.1 Global Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
- 5.2 Global Biopharmaceutical and Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Biopharmaceutical and Vaccines Market Size (2015-2020)
- 6.2 Biopharmaceutical and Vaccines Key Players in North America (2019-2020)
- 6.3 North America Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 6.4 North America Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Biopharmaceutical and Vaccines Market Size (2015-2020)
- 7.2 Biopharmaceutical and Vaccines Key Players in Europe (2019-2020)
- 7.3 Europe Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 7.4 Europe Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
8 China
- 8.1 China Biopharmaceutical and Vaccines Market Size (2015-2020)
- 8.2 Biopharmaceutical and Vaccines Key Players in China (2019-2020)
- 8.3 China Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 8.4 China Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Biopharmaceutical and Vaccines Market Size (2015-2020)
- 9.2 Biopharmaceutical and Vaccines Key Players in Japan (2019-2020)
- 9.3 Japan Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 9.4 Japan Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Biopharmaceutical and Vaccines Market Size (2015-2020)
- 10.2 Biopharmaceutical and Vaccines Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 10.4 Southeast Asia Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
11 India
- 11.1 India Biopharmaceutical and Vaccines Market Size (2015-2020)
- 11.2 Biopharmaceutical and Vaccines Key Players in India (2019-2020)
- 11.3 India Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 11.4 India Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Biopharmaceutical and Vaccines Market Size (2015-2020)
- 12.2 Biopharmaceutical and Vaccines Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Biopharmaceutical and Vaccines Market Size by Type (2015-2020)
- 12.4 Central & South America Biopharmaceutical and Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Novartis
- 13.1.1 Novartis Company Details
- 13.1.2 Novartis Business Overview and Its Total Revenue
- 13.1.3 Novartis Biopharmaceutical and Vaccines Introduction
- 13.1.4 Novartis Revenue in Biopharmaceutical and Vaccines Business (2015-2020))
- 13.1.5 Novartis Recent Development
- 13.2 Pfizer
- 13.2.1 Pfizer Company Details
- 13.2.2 Pfizer Business Overview and Its Total Revenue
- 13.2.3 Pfizer Biopharmaceutical and Vaccines Introduction
- 13.2.4 Pfizer Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.2.5 Pfizer Recent Development
- 13.3 Sanofi
- 13.3.1 Sanofi Company Details
- 13.3.2 Sanofi Business Overview and Its Total Revenue
- 13.3.3 Sanofi Biopharmaceutical and Vaccines Introduction
- 13.3.4 Sanofi Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.3.5 Sanofi Recent Development
- 13.4 Roche
- 13.4.1 Roche Company Details
- 13.4.2 Roche Business Overview and Its Total Revenue
- 13.4.3 Roche Biopharmaceutical and Vaccines Introduction
- 13.4.4 Roche Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.4.5 Roche Recent Development
- 13.5 Abbott
- 13.5.1 Abbott Company Details
- 13.5.2 Abbott Business Overview and Its Total Revenue
- 13.5.3 Abbott Biopharmaceutical and Vaccines Introduction
- 13.5.4 Abbott Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.5.5 Abbott Recent Development
- 13.6 Biogen Idec
- 13.6.1 Biogen Idec Company Details
- 13.6.2 Biogen Idec Business Overview and Its Total Revenue
- 13.6.3 Biogen Idec Biopharmaceutical and Vaccines Introduction
- 13.6.4 Biogen Idec Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.6.5 Biogen Idec Recent Development
- 13.7 Regeneron Pharmaceuticals
- 13.7.1 Regeneron Pharmaceuticals Company Details
- 13.7.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
- 13.7.3 Regeneron Pharmaceuticals Biopharmaceutical and Vaccines Introduction
- 13.7.4 Regeneron Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.7.5 Regeneron Pharmaceuticals Recent Development
- 13.8 Alexion Pharmaceuticals
- 13.8.1 Alexion Pharmaceuticals Company Details
- 13.8.2 Alexion Pharmaceuticals Business Overview and Its Total Revenue
- 13.8.3 Alexion Pharmaceuticals Biopharmaceutical and Vaccines Introduction
- 13.8.4 Alexion Pharmaceuticals Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.8.5 Alexion Pharmaceuticals Recent Development
- 13.9 Johnson and Johnson
- 13.9.1 Johnson and Johnson Company Details
- 13.9.2 Johnson and Johnson Business Overview and Its Total Revenue
- 13.9.3 Johnson and Johnson Biopharmaceutical and Vaccines Introduction
- 13.9.4 Johnson and Johnson Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.9.5 Johnson and Johnson Recent Development
- 13.10 GlaxoSmithKline
- 13.10.1 GlaxoSmithKline Company Details
- 13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
- 13.10.3 GlaxoSmithKline Biopharmaceutical and Vaccines Introduction
- 13.10.4 GlaxoSmithKline Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 13.10.5 GlaxoSmithKline Recent Development
- 13.11 Merck
- 10.11.1 Merck Company Details
- 10.11.2 Merck Business Overview and Its Total Revenue
- 10.11.3 Merck Biopharmaceutical and Vaccines Introduction
- 10.11.4 Merck Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 10.11.5 Merck Recent Development
- 13.12 Lonza
- 10.12.1 Lonza Company Details
- 10.12.2 Lonza Business Overview and Its Total Revenue
- 10.12.3 Lonza Biopharmaceutical and Vaccines Introduction
- 10.12.4 Lonza Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 10.12.5 Lonza Recent Development
- 13.13 Boehringer Ingelheim
- 10.13.1 Boehringer Ingelheim Company Details
- 10.13.2 Boehringer Ingelheim Business Overview and Its Total Revenue
- 10.13.3 Boehringer Ingelheim Biopharmaceutical and Vaccines Introduction
- 10.13.4 Boehringer Ingelheim Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 10.13.5 Boehringer Ingelheim Recent Development
- 13.14 Rentschler
- 10.14.1 Rentschler Company Details
- 10.14.2 Rentschler Business Overview and Its Total Revenue
- 10.14.3 Rentschler Biopharmaceutical and Vaccines Introduction
- 10.14.4 Rentschler Revenue in Biopharmaceutical and Vaccines Business (2015-2020)
- 10.14.5 Rentschler Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Biopharmaceutical and Vaccines. Industry analysis & Market Report on COVID-19 Impact on Global Biopharmaceutical and Vaccines is a syndicated market report, published as COVID-19 Impact on Global Biopharmaceutical and Vaccines Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Biopharmaceutical and Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
